Improving genetic testing for colorectal cancer patients
Official title: Piloting an Implementation Strategy for Mainstream Genetic Testing in Colorectal Cancer
Funded at University of Alabama at Birmingham · NIH-10948473 · Data updated 2026-11-12
This study is all about making it easier for colorectal cancer patients to get genetic testing by helping doctors and nurses who aren't genetic experts learn how to guide patients through the process, so they can make better choices about their treatment and screenings.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $192,433 |
| NIH project number | 1K08CA293312-01 |
| Project ID | NIH-10948473 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with colorectal cancer who may benefit from genetic testing.
✕Less likely to help
Patients who do not have colorectal cancer or those who have already undergone genetic testing may not receive any benefit from this research.
What this research studies
This research aims to enhance the implementation of genetic testing for colorectal cancer (CRC) patients by identifying and addressing barriers that prevent widespread adoption. It focuses on training non-genetic healthcare providers to conduct pre-test counseling and coordinate genetic testing, which could lead to better patient outcomes. By piloting a tailored multi-level implementation strategy, the project seeks to increase the percentage of CRC patients who receive genetic testing, thereby informing their treatment and screening options. The study will involve assessing the perspectives of various healthcare professionals involved in the care of CRC patients.
Why it matters
Potential benefit: If successful, this research could significantly increase the rates of genetic testing in colorectal cancer patients, leading to improved treatment and prevention strategies.
How similar studies have gone: Previous research has shown that mainstream genetic testing can effectively increase testing rates, indicating that this approach has potential for success.
Where this research is happening
-
University of Alabama at Birmingham
Birmingham, United States Active
Researchers
- Principal investigator: Hollis, Robert H — University of Alabama at Birmingham
- Study coordinator: Hollis, Robert H
Related research
Other NIH-funded projects on the same topics.
-
Improving colorectal cancer screening and follow-up care.
This study is working to help more people get screened for colorectal cancer and receive the follow-up care they need, especially those who haven't been screened much before, so that everyone can have better access to important health checks and improve their overall health.
-
Colorectal cancer prognosis through a broad, collaborative study
A large, multi-center study follows people newly diagnosed with colorectal cancer to find biomarkers and patterns that predict outcomes and guide future care.
-
Ceramides and how they affect metabolism and colorectal cancer in adults
A study in adults with obesity-related health issues will explore how a fat-related molecule called ceramide influences metabolic problems and colorectal cancer risk.
-
Automated point-of-care DNA methylation test for colorectal cancer in LMICs
A fast, affordable blood test using DNA markers to help identify people at higher risk of colorectal cancer in low- and middle-income countries.
-
Rewiring Colorectal Cancer to Harness Therapeutic Hyperactivation
A Yale team is exploring brain-storming new ways to treat colorectal cancer by safely boosting certain cancer signaling pathways to kill cancer cells and by reshaping cancer cell states to improve responses to existing therapies.
-
Comparative modeling to guide colorectal cancer screening and care
A researcher team will use computer models to study how access to care, risk, and new screening options affect colorectal cancer outcomes and costs for adults in the US.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.